Impact Factor
3.66
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.32
545 total citations
h5-index
34
h5 depth signal
Cited share
77.7%
101 of 130
Total citations
545
Citation footprint
Metric signal
3.76
External metric anchor
Self-citation
7.0%
38 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
526
United Kingdom
144
Germany
84
China
56
Sweden
46
Citing Fields of Research
Cell Biology
150
Mass Spectrometry
135
Cellular Membrane Transporters & Receptors
88
Cancer & Development
87
Immunology
81
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,070
Articles tracked across the journal lifetime
Indexed publication set
130
101 cited publications
Last 12 months
59
5.4 publications/month
Open access share
100.0%
59 OA publications in the last year
Leading citing country
United States
526 citing publications
Leading citing field
Cell Biology
150 citing publications
Latest tracked publication
11 October 2026
10 recent records available
Coverage & Indexing History
v22n1, 2017-
v22n1, 2017-
Research Focus & Classification
Indexed Subjects
Immunology
Cell Biology
Mass Spectrometry
Virology
Cancer & Development
Cancer, Autophagy & Apoptosis
Cellular Membrane Transporters & Receptors
Issuing & Sponsoring Bodies
issuing body
Society for Laboratory Automation and Screening
Broad Categories
Molecular Biology
Virology
Cancer & Development
Immunotherapy
Protein Structure & Folding
Stem Cell Biology
Photochemistry
Cancer, Autophagy & Apoptosis
MeSH Descriptors
Drug Discovery
Molecular Targeted Therapy
Technology, Pharmaceutical
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.slasd.2026.100343
Open DOI
Machine Learning-Based Brightfield Detection of Anti-Fibrotic Effects in a 3D Retinal Fibrosis Model
02
DOI 10.1016/j.slasd.2026.100342
Open DOI
High-throughput discovery of actin-binding compounds for cardiac disorders
03
DOI 10.1016/j.slasd.2026.100341
Open DOI
Probing and painting to get the full picture of macrophage polarisation
04
05
DOI 10.1016/j.slasd.2026.100340
Open DOI
Hit selection using SSMD-based machine learning performance metrics in high-throughput screening assays
06
DOI 10.1016/j.slasd.2026.100338
Open DOI
From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease
07
DOI 10.1016/j.slasd.2026.100335
Open DOI
Decision-grade evidence for AI-enabled small-molecule discovery
08
DOI 10.1016/j.slasd.2026.100334
Open DOI
MitoLatentProfiler: ROI-constrained deep learning for mitochondrial phenotyping in human myotubes
09
DOI 10.1016/j.slasd.2026.100337
Open DOI
High-content imaging workflow for single-cell drug response profiling of acute myeloid leukemia subtypes
10
DOI 10.1016/j.slasd.2026.100333
Open DOI